Demegen, Inc.
Records under this name other than patents Demegen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,084,156 | Plants producing lytic peptides Formerly held Term ended Term ended Jun 28, 2019 · From the USPTO record | Term ended | Term ended Jun 28, 2019 | From the USPTO record |
| US 6,514,692 | Method for treatment of immunodeficiency virus infection Term ended Term ended Apr 2, 2019 · From the USPTO record | Term ended | Term ended Apr 2, 2019 | From the USPTO record |
| US 6,191,110 | Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides Term ended Term ended Jan 19, 2019 · From the USPTO record | Term ended | Term ended Jan 19, 2019 | From the USPTO record |
| US 6,528,488 | Method for treating cystic fibrosis Term ended Term ended Jan 8, 2019 · From the USPTO record | Term ended | Term ended Jan 8, 2019 | From the USPTO record |
| US 6,531,573 | Antifungal and antibacterial peptides Term ended Term ended Dec 18, 2017 · From the USPTO record | Term ended | Term ended Dec 18, 2017 | From the USPTO record |
| US 6,559,281 | Non-naturally occurring synthetic lytic peptides Lapsed on the fee record Ended May 6, 2011 · From the USPTO record | Lapsed on the fee record | Ended May 6, 2011 | From the USPTO record |
| US 6,448,391 | Ubiquitin-lytic peptide gene promoter Lapsed on the fee record Ended Sep 10, 2010 · From the USPTO record | Lapsed on the fee record | Ended Sep 10, 2010 | From the USPTO record |
| US 6,018,102 | Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same Lapsed on the fee record Ended Jan 25, 2008 · From the USPTO record | Lapsed on the fee record | Ended Jan 25, 2008 | From the USPTO record |
| US 6,153,210 | Use of locally delivered metal ions for treatment of periodontal disease Lapsed on the fee record Ended Nov 28, 2004 · From the USPTO record | Lapsed on the fee record | Ended Nov 28, 2004 | From the USPTO record |
| US 5,955,573 | Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same Term ended Term ended no later than Sep 21, 2019 · Low confidence | Term ended | Term ended no later than Sep 21, 2019 | Low confidence |